Predictor Factors of Prism Effectiveness in Young Adults With Convergence Insufficiency Publisher Pubmed



Hashemi H¹ ; Jafarzadehpur E² ; Nabovati P² ; Yekta A³ ; Aghamirsalim M⁴ ; Kamali M² ; Mirzajani A² ; Khabazkhoob M⁵ Show Affiliations
Source: Clinical and Experimental Optometry Published:2021

Abstract

Clinical relevance: The findings of this study can be useful in the process of patient selection as well as in optimising the prescription of the prism in patients with convergence insufficiency. Background: To determine the relationship between the demographic variables and baseline clinical characteristics with the prism effectiveness in young adults with convergence insufficiency. Methods: Sixty-four young adults with convergence insufficiency entered a randomised clinical trial and were randomly assigned to either treatment or placebo groups. For participants in the treatment group, the near optical correction containing base-in prism was determined based on the Sheard’s criterion. Participants in the placebo group received near optical correction. After three months of using the assigned correction, the outcome examinations were performed. Results: In the univariate analysis, a remote near point of convergence, a higher baseline symptoms score, and a higher prescribed prism power showed a significant relationship with the increase in prism effectiveness. A significant inverse relationship was found between the near positive fusional vergence, vergence facility, and prism adaptation rate with the prism effectiveness. Based on the results of the multiple regression, the prism adaptation rate was the only independent predictor factor of prism effectiveness, so that the prism effectiveness increased by 0.60 for each per cent reduction in prism adaptation rate. Conclusion: Prism adaptation is the only independent predictive factor of prism effectiveness in young adults with convergence insufficiency. Based on the findings of the present study, it is recommended that careful assessment of prism adaptation be considered before considering prism prescription. © 2021 Optometry Australia.